- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Percheron Therapeutics Ltd (PER)
Track today's live Percheron Therapeutics (PER) share price, performance and key data on this page with our current Sydney:PER stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Percheron Therapeutics share price on the Sydney exchange. Use the dropdown to switch exchange for the PER share price, head to our technical summary section, which provides analysis on Percheron Therapeutics share price buy/sell indicators using real-time data (or discuss the Percheron Therapeutics (PER) stock price today with other investors in the Percheron Therapeutics ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:PER share price (ISIN: AU0000317281) to enhance your trading decisions with our free investment tools and resources.
What Is the Percheron Therapeutics Ltd Share Price Today?
The Percheron Therapeutics share price today is 0.006.
What Is the Stock Symbol for Percheron Therapeutics Ltd
The stock symbol (or 'ticker') for Percheron Therapeutics Ltd is "PER."
What Stock Exchange Does Percheron Therapeutics Ltd Trade On?
Percheron Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Percheron Therapeutics Ltd a Good Stock to Buy?
Determining whether Percheron Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:PER share price (ISIN: AU0000317281) to enhance your trading decisions with our free investment tools and resources.
What Is the Percheron Therapeutics Ltd Share Price Today?
The Percheron Therapeutics share price today is 0.006.
What Is the Stock Symbol for Percheron Therapeutics Ltd
The stock symbol (or 'ticker') for Percheron Therapeutics Ltd is "PER."
What Stock Exchange Does Percheron Therapeutics Ltd Trade On?
Percheron Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Percheron Therapeutics Ltd a Good Stock to Buy?
Determining whether Percheron Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Sydney
Currency in AUD
0.006
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.006
0.006
52 wk Range
0.002
0.010
PER is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0060.006
52 wk Range
0.0020.010
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PER Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
26/02/2026
EPS / Forecast
-- / -3.60
Revenue / Forecast
88.41K / --
Compare PER to Peers and Sector
Metrics to compare | PER | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPERPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −3.5x | −0.3x | |
PEG Ratio | −0.03 | 0.04 | 0.00 | |
Price/Book | 1.2x | 4.2x | 2.6x | |
Price / LTM Sales | 10.8x | 15.5x | 3.1x | |
Upside (Analyst Target) | - | 86.3% | 47.6% | |
Fair Value Upside | Unlock | −3.3% | 5.6% | Unlock |
Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Percheron Therapeutics (Sydney: PER) Share Price Today?
The Percheron Therapeutics stock price today is 0.006 AUD.
What Stock Exchange Does Percheron Therapeutics (PER) Trade On?
Percheron Therapeutics is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Percheron Therapeutics?
The stock symbol (also called a 'ticker') for Percheron Therapeutics is "PER."
What Is the Current Percheron Therapeutics Market Capitalisation?
As of today, Percheron Therapeutics (Sydney: PER) market cap is 8.370M AUD.
What Is Percheron Therapeutics's (PER) Earnings Per Share (TTM)?
The Percheron Therapeutics EPS is currently -0.004 (Trailing Twelve Months).
Is PER a Buy or Sell From a Technical Analyst Perspective?
Based on today's Percheron Therapeutics moving averages and other technical indicators, the daily buy/sell signal for PER stock is Strong Buy.
How Many Times Has Percheron Therapeutics Stock Split?
Percheron Therapeutics has split 3 times. (See the PER stock split history page for full effective split date and price information.)
How Many Employees Does Percheron Therapeutics Have?
Percheron Therapeutics has 8 employees, based on their latest Companies House report.
What is the current trading status of Percheron Therapeutics (Sydney: PER)?
As of 21/08/2026, Percheron Therapeutics (PER) is trading at a share price of 0.006 AUD, with a previous close of 0.006 AUD. The stock has fluctuated within a day range of 0.006 AUD to 0.006 AUD, while its 52-week range spans from 0.002 AUD to 0.010 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.